SoftBank Group and Tempus establish a joint venture "SB TEMPUS" to further advance healthcare in Japan by leveraging medical data and AI.
TEMPUS
SoftBank-backed Tempus AI sets IPO price at $37 per share and aims at raising $410.7 million, reflecting strong investor interest.
Popular Posts
